Calendula ungventum (Ointment) Instructions for Use
ATC Code
D11A (Other dermatological preparations)
Active Substance
Calendulae flos (DAB German Pharmacopoeia)
Clinical-Pharmacological Group
Herbal preparation with anti-inflammatory and tissue regeneration improving action for external use
Pharmacotherapeutic Group
Antiseptic and anti-inflammatory agent of plant origin
Pharmacological Action
A herbal preparation. It exerts an antiseptic and local anti-inflammatory action.
It contains triterpene saponins – glycosides A-F; triterpene alcohols – monools, diols, triols; flavonoids, including isorhamnetin and quercetin glycosides; hydroxycoumarins, including scopoletin, umbelliferone, esculetin; carotenoids – lutein, zeaxanthin; essential oils – alpha-cadinol, T-cadinol, fatty acids; water-soluble polysaccharides – rhamnoarabinogalactans, arabinogalactans. It has an anti-inflammatory effect and reduces capillary permeability. Due to the presence of terpene alkaloids, lactone, and flavones, it exhibits antimicrobial activity.
Indications
- Minor skin injuries such as small cuts, scrapes, and abrasions.
- Superficial burns, including those caused by sun exposure.
- Insect bites for symptomatic relief of local skin irritation.
ICD codes
| ICD-10 code | Indication |
| T14.0 | Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect) |
| ICD-11 code | Indication |
| EH92 | Dermatoses provoked by friction or mechanical impact |
| EH92.1 | Blister due to friction |
| ND56.0 | Superficial injury of unspecified body region |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply the ointment 2 to 3 times daily directly onto the affected skin areas. Use a thin layer and gently rub it in.
Ensure the skin is clean and dry before each application. This product is for external use only. Do not use on large areas of the body or under occlusive dressings unless directed by a physician.
Adverse Reactions
Local allergic skin reactions are possible, including redness, swelling, rash, itching, and urticaria. Contact dermatitis at the site of application may occur rarely.
Discontinue use immediately and consult a physician if any signs of a hypersensitivity reaction develop, such as severe itching, spreading rash, or angioedema.
Drug Interactions
No specific drug interactions are currently known for topical application. The potential for interaction with other topically applied medicinal products exists.
Avoid concurrent use with other topical preparations on the same area of skin to prevent incompatibility. Inform your physician about all medications you are using.
Contraindications
- Hypersensitivity to Calendula officinalis or any of the excipients in the ointment base.
- Known allergy to plants of the Asteraceae/Compositae family (e.g., arnica, chamomile, ragweed, tansy, wormwood, aster, chrysanthemum).
- Application to deep or infected wounds and severe burns requiring medical attention.
Overdose
Overdose from topical application is unlikely due to minimal systemic absorption. Excessive application may increase the risk of local adverse reactions.
In case of accidental ingestion, seek medical attention. Symptoms may include gastrointestinal discomfort. Treatment should be symptomatic and supportive.
Use in Pregnancy and Lactation
If use during pregnancy and breastfeeding is necessary, the expected benefit for the mother and the potential risk to the fetus or child should be considered.
Use in Hepatic Impairment
Use with caution for oral administration in liver diseases.
Pediatric Use
Oral administration is contraindicated in children and adolescents under 12 years of age.
Geriatric Use
The drug is approved for use in elderly patients.
Special Precautions
Avoid contact of this product with the eyes.
If a secondary infection occurs during treatment, antibacterial or antifungal therapy as prescribed by a doctor may be required.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Barnaul Pharmaceutical Factory, State Enterprise (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Vladivostok Pharmaceutical Factory, JSC (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Volgograd Pharmaceutical Factory State Enterprise (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Yekaterinburg Pharmaceutical Factory, PJSC (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Kaliningrad Pharmaceutical Factory, OJSC (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Krasnodar Pharmaceutical Factory, PJSC (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Novosibirsk Pharmaceutical Factory OJSC (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Omsk Pharmaceutical Factory, SUE (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Pskov Pharmaceutical Factory, SUE (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Pyatigorsk Pharmaceutical Factory LLC (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Tver Pharmaceutical Factory, PJSC (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Pharmaceutical Factory Of St. Petersburg, PJSC (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Astrakhan Pharmaceutical Factory FSUE (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Kopeysk Pharmaceutical Factory, JSC (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Pharmstandard-Fitopharm-NN LLC (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Akrikhin Chemical and Pharmaceutical Plant, JSC (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
UNIPHARM, LLC (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jars 25 g or 40 g
Marketing Authorization Holder
Yaroslavl Pharmaceutical Factory, CJSC (Russia)
Dosage Form
| Calendula ungventum | Ointment for external use 10 g/100 g: jars 25 g or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
25 g – jars.
40 g – jars.
Ointment for external use 10 g/100 g: jar 15 g, 25 g, or 40 g
Marketing Authorization Holder
Borisov Plant Of Medical Preparations, PJSC (Republic Of Belarus)
Dosage Form
| Calendula | Ointment for external use 10 g/100 g: jar 15 g, 25 g, or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Calendula tincture | 10 g |
15 g – dark glass jars (1) – cardboard packs.
25 g – dark glass jars (1) – cardboard packs.
40 g – dark glass jars (1) – cardboard packs.
